CN101690772A - Medicine for curing tuberculous pleuritis and eliminating pleural effusion - Google Patents
Medicine for curing tuberculous pleuritis and eliminating pleural effusion Download PDFInfo
- Publication number
- CN101690772A CN101690772A CN200910027861A CN200910027861A CN101690772A CN 101690772 A CN101690772 A CN 101690772A CN 200910027861 A CN200910027861 A CN 200910027861A CN 200910027861 A CN200910027861 A CN 200910027861A CN 101690772 A CN101690772 A CN 101690772A
- Authority
- CN
- China
- Prior art keywords
- medicine
- eliminating
- pleural effusion
- tuberculous pleuritis
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine prepared from traditional Chinese herbal medicines for curing tuberculous pleuritis and eliminating pleural effusion. The medicine is characterized in that the medicine comprises the following important medicines: 40-75g of euphorbia splendens, 22-38g of the flower of lilac daphne, 60-100g of the root of leek, 100-140g of rltalaindica and 40-60g of the seed of bitter gourd. The preparation has well-organized principal and subordinate medicine, perfect compatibility and powerful potent effect and fully embodies the therapeutic principles of removing phlegm and alleviating water retention, relieving Qi and eliminating stasis, clearing away heat and toxic material and promoting urination.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of tuberculous pleuritis and eliminating pleural effusion, particularly form by Chinese herbal medicine.
Tuberculous pleuritis is a kind of infectious disease that is caused by tubercule bacillus, and tuberculosis is a kind of disease of serious harm human health.After the antituberculotics invention, just be able to preliminary control, now because the increase of movement of population amount.The number that infects tulase is on the rise, because original antituberculotics is adapted to by antibacterial gradually, produces the drug resistance Drug resistance again.The tulase that adds variation constantly generates, and original antitubercular agent curative effect is reduced.
Western medical treatment tuberculous pleuritis hydrothorax generally adopts puncture to draw water at present, operative drainage, and antibiotics transfusion, puncture are drawn water needs repeated multiple times and dangerous, and operative drainage causes wound painful big to the patient.The Chinese medicine treasure-house also has this sick document record of treatment.Clinical therapeutic efficacy is also undesirable.
Summary of the invention
The objective of the invention is to have shortcoming, and a kind of eutherapeutic medicine for the treatment of the tuberculous pleuritis hydrothorax is provided at existing medicine.Related tuberculous pleuritis is moist tuberculous pleuritis.
For achieving the above object, the present invention is by the following technical solutions:
A kind of medicine for the treatment of tuberculous pleuritis and eliminating pleural effusion, it is by following weight
Raw material Chinese medicine is formed:
Caulis et folium euphorbiae milii 40-75 gram Herba Clinopodii Polycephali 100-140 gram
Flos Genkwa 22-38 restrains bitter kettle 40-60 gram
Radix et Bulbus Allii tuberosi 60-100 gram
Realize preferred plan of the present invention by component weight:
Caulis et folium euphorbiae milii 60 gram Herba Clinopodii Polycephalies 120 grams
Bitter kettle 50 grams of Flos Genkwa 30 grams
Radix et Bulbus Allii tuberosi 80 grams
Process for preparing medicine of the present invention is:
Flos Genkwa fried with vinegar dry pulverizing respectively with Caulis et folium euphorbiae milii, Radix et Bulbus Allii tuberosi, Herba Clinopodii Polycephali, Semen Lagenariae gourdae later, cross 80 mesh sieves, mix homogeneously incapsulates, and each capsule is by 0.35 gram dress, and collection gets final product.
The effect achievement:
The present invention treats each Chinese medicine component in the medicine of tuberculous pleuritis and eliminating pleural effusion:
Caulis et folium euphorbiae milii, Flos Genkwa be with relieving oedema or abdominal distension through diuresis or purgation function, but two its rows of relieving oedema or abdominal distension through diuresis or purgation that combine are dense, and the effect of clearing away phlegm is stronger.It is to promote the efficacy of a drug speed of service that Radix et Bulbus Allii tuberosi has its effect of effect of circulation of qi promoting dissipating blood stasis.The effect of Herba Clinopodii Polycephali, Semen Lagenariae gourdae two medicine clearing away heat and promoting diuresis.Diseases caused by retention of fluid is divided from urine to disappear.Therefore the present invention has clearing away phlegm to relieve oedema or abdominal distension through diuresis or purgation, circulation of qi promoting dissipating blood stasis, heat-clearing and toxic substances removing, the function of tonneau urine.
The present invention has compared following advantage with conventional medicament:
The present invention is a pure Chinese medicinal preparation, and toxic and side effects is little, treats rapid-actionly, and preparation method is simple, and medical expense is low.
Indication of the present invention: the hydrothorax of tuberculous pleuritis, whole body each several part hydrops diseases caused by retention of fluid such as ascites, swelling.
Instructions of taking: after meal half an hour oral, eliminating cold for resuscitation water send down, every day secondary, from one cumulative, be no more than 8 at most, the anemia of pregnant woman has bleeding tendency, the body constitution difference is avoided clothes, drug withdrawal immediately after mark disease is eliminated.
For showing among the present invention medicine to tuberculous pleuritis hydrothorax therapeutic effect, through two routine patients' clinical observation: 2 examples are the male, and the age is 31 years old, 74 years old.
One, diagnostic criteria: all diagnosis is as the criterion according to County Hospital.
Two, observational technique: clinical symptoms performance before and after the contrast therapy.
Three, medication: every day secondary, each 2, observe clinical symptoms every day.
Four, curative effect determinate standard
1, cure: hydrothorax is eliminated substantially.
2, effective: hydrothorax partly reduces.
3, invalid: hydrothorax does not reduce before and after the treatment.
Five, observe conclusion: cure 1 example, effective 1 example.
The specific embodiment
Flos Genkwa fried with vinegar dry pulverizing respectively with Caulis et folium euphorbiae milii, Radix et Bulbus Allii tuberosi, Herba Clinopodii Polycephali, Semen Lagenariae gourdae later, cross 80 mesh sieves, mix homogeneously incapsulates, and each capsule is by 0.35 gram dress.Instructions of taking: every day secondary, one after each meal, eliminating cold for resuscitation water send down, observes clinical symptoms every day, the anemia of pregnant woman, the more weak clothes of bleeding tendency and body constitution is arranged.
Ding Yunjun, man, birth in 79 years, suffer from tuberculous pleuritis in August, 2007, the Wuhe County county hospital is lived in cough, heating, and puncture is drawn water, instillation sodium succinate hydrocortisone was so treated one month, and still the jede Woche thoracic cavity produces more than 1000 milliliter of hydrops, behind hospital's drawing liquid 4 times, decision is its drain of performing an operation, and the patient is afraid of suffer, looks for me to treat, every day 3 times, each 2.(take me invention medicine 2) taken after three days and used the color ultrasound observed result, the hydrothorax light that dissipated substantially, and after I will produce the hydrops root and eliminate with another kind of medicine, the patient did not produce hydrothorax in 1 year again.
Yang Jiangong.The man, 74 years old, the autumn in 2008 was suffered from pulmonary carcinoma late period, the children guard that changes shifts every day, the patient goes into a coma and reach more than 16 hours every day, and mouth, the bullate Zhang Bukai of eye take one week of medicine of the present invention, and patient's swelling disappears, it is free movable to get up, after patient's swelling disappears, dead after living 28 days more.
Claims (1)
1. medicine for the treatment of tuberculous pleuritis and eliminating pleural effusion is characterized in that it contains the material medicine of following weight: Caulis et folium euphorbiae milii 40-75 gram, Flos Genkwa 22-38 gram, Radix et Bulbus Allii tuberosi 60-100 gram, Herba Clinopodii Polycephali 100-140 gram, Semen Lagenariae gourdae 40-60 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910027861A CN101690772A (en) | 2009-05-18 | 2009-05-18 | Medicine for curing tuberculous pleuritis and eliminating pleural effusion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910027861A CN101690772A (en) | 2009-05-18 | 2009-05-18 | Medicine for curing tuberculous pleuritis and eliminating pleural effusion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101690772A true CN101690772A (en) | 2010-04-07 |
Family
ID=42079521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910027861A Pending CN101690772A (en) | 2009-05-18 | 2009-05-18 | Medicine for curing tuberculous pleuritis and eliminating pleural effusion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101690772A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922528A (en) * | 2015-07-14 | 2015-09-23 | 花宝金 | Medicine composite for treating malignant pleural effusion and preparation method and purpose thereof |
-
2009
- 2009-05-18 CN CN200910027861A patent/CN101690772A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922528A (en) * | 2015-07-14 | 2015-09-23 | 花宝金 | Medicine composite for treating malignant pleural effusion and preparation method and purpose thereof |
| CN104922528B (en) * | 2015-07-14 | 2018-08-28 | 花宝金 | A kind of pharmaceutical composition and its preparation method and application for treating malignant pleural effusion |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102949661B (en) | External pharmaceutical composition for conditioning breast and preparation method thereof | |
| CN103301400A (en) | Traditional Chinese medicinal composition for treating chronic atrophic gastritis and preparation method of traditional Chinese medicinal composition | |
| CN102319397A (en) | Chinese medicinal decoction for treating chronic pelvic inflammatory disease with clystering method | |
| CN104771671A (en) | Traditional Chinese medicine lotion for treating gynecological inflammation | |
| CN103202999B (en) | Modified peach pit flatus-smoothing oral liquid used for operative complications and preparation method thereof | |
| CN102526620B (en) | Traditional Chinese medicinal composition for treating gynecological inflammation and application of same | |
| CN102872300B (en) | Traditional Chinese medicine for treating non-gonococcal urethritis | |
| CN101869636A (en) | Granulation-promoting paste with main components of sinkiang arnebia root and sesame oil | |
| CN101530516B (en) | Chinese medicament for treating appendicitis | |
| CN101690772A (en) | Medicine for curing tuberculous pleuritis and eliminating pleural effusion | |
| CN103860894B (en) | A kind of medicine for the treatment of chronic prostatitis | |
| CN103316238B (en) | Traditional Chinese medicine for treating infertility due to cold uterus | |
| CN102125612B (en) | Chinese medicinal preparation for treating acute lumbar sprain | |
| CN104622995A (en) | Pharmaceutical composition for treating chronic superficial gastritis and preparation method of pharmaceutical composition | |
| CN104258113B (en) | A kind of Chinese medicine composition for the treatment of cerebral hemorrhage | |
| CN104758462B (en) | A kind of powder for the treatment of acute cholecystitis | |
| CN106822524B (en) | Compound medicine for treating infertility and preparation method and application thereof | |
| CN103211891A (en) | Externally-applied Chinese medicinal preparation for treating bone traumatic osteomyelitis | |
| CN102228661B (en) | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis | |
| CN107334941A (en) | A kind of Chinese medicine for treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN106266970B (en) | A kind of Chinese medicine composition treated production and cause endometritis | |
| CN101181471B (en) | Medicament for curing pelvic inflammatory disease and preparation method thereof | |
| CN105232971A (en) | Traditional Chinese medicine composition for treating metrorrhagia and metrostaxis with kidney yin deficiency symptom | |
| CN103784946B (en) | A kind of pharmaceutical composition treating condyloma acuminatum | |
| CN103860982B (en) | A kind of clinical care is treated the medicine of acute skin injury induced by iradiation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100407 |